Pfizer’s Maternal RSV Vaccine: A Breakthrough for Infant Health
US FDA Approves Pfizer’s Maternal RSV Vaccine to Protect Infants The US Food and Drug Administration (FDA) has recently granted approval to Pfizer’s Maternal Respiratory Syncytial Virus (RSV) Vaccine, marking a significant development in maternal and infant healthcare. This groundbreaking vaccine is designed to safeguard infants against the potentially severe and sometimes life-threatening effects of…